Litigation

Recent Posts

N.J. Jury Finds For Defendant Novartis In Zometa Jaw Injury Trial
Posted on 16 May 2013 by Tom Moylan

NEW BRUNSWICK, N.J. - (Mealey's) A New Jersey state court jury on May 15 returned a defense verdict for Novartis Pharmaceuticals Corp. in a Zometa jaw injury case, a source told Mealey Publications ( Beverly Meng v. Novartis Pharmaceuticals Corp.... Read More

Tags: Beverly Meng v. Novartis Pharmaceuticals Corp. , osteonecrosis of the jaw , Novartis Pharmaceuticals , Middlesex County Superior Court , Beverly Meng , New Jersey , ONJ , Litigation , Zometa , verdict

Jury Awards Plaintiff $8 Million In Fosamax Lawsuit
Posted on 29 Jun 2010 by Tom Moylan

NEW YORK - (Mealey's) A jury returned an $8 million compensatory damages verdict against Merck & Co. Inc. on June 25 in the U.S. District Court for the Southern District of New York in the retrial of the first Fosamax multidistrict litigation... Read More

Tags: osteonecrosis of the jaw , Merck & Co. Inc. , personal injury , ONJ , Shirley Boles v. Merck & Co. , Litigation , multidistrict litigation , lawsuit , Shirley Boles , Fosamax , torts , osteoporosis , In Re: Fosamax Products Liability Litigation

Second Fosamax Bellwether Case Ends In Unanimous Verdict For Defendant Merck
Posted on 6 May 2010 by Tom Moylan

NEW YORK — (Mealey’s) The second federal Fosamax bellwether trial ended in a defense verdict May 6 when a jury in the U.S. District Court for the Southern District of New York unanimously found that the plaintiff did not suffer from osteonecrosis... Read More

Tags: osteonecrosis of the jaw , Louise Maley , personal injury , ONJ , Merck , Litigation , lawsuit , Fosamax , In Re: Fosamax Products Liability Litigation , torts

$8M Fosamax Verdict Remitted By MDL Judge To $1.5M Or New Damages Trial
Posted on 5 Oct 2010 by Tom Moylan

NEW YORK -- (Mealey's) The New York federal judge overseeing the Fosamax multidistrict litigation on Oct. 4 sua sponte found that an $8 million verdict in a bellwether trial is excessive and ordered a remittitur of the verdict to $1.5 million unless... Read More

Tags: Douglas & London , punitive damages , Damages , bisphosphonate , osteonecrosis of the jaw , personal injury , Judge John F. Keenan , product liability , Trial , MDL. Shirley Boles v. Merck & Co. , ONJ , Merck , Litigation , osteoporosis drug , multidistrict litigation , Fosamax multidistrict litigation , lawsuit , Shirley Boles , Fosamax , verdict , torts , Gary Douglas , In Re: Fosamax Products Liability Litigation

N.J. Jury Finds Novartis Didn't Fail To Warn About Jaw Risk From Aredia, Zometa Bone Drugs
Posted on 7 Oct 2010 by Tom Moylan

NEW BRUNSWICK, N.J. -- A New Jersey state court jury on Oct. 6 found that Novartis Pharmaceuticals Corp. did not fail to provide adequate warning to a cancer patient's doctor that its bone-saving drugs Aredia and Zometa had a risk of osteonecrosis... Read More

Tags: chemotherapy , osteomyelitis , osteonecrosis of the jaw , Novartis Pharmaceuticals , personal injury , Jane Bessemer v. Novartis Pharmaceuticals Corp. , Jane Bessemer , ONJ , cancer , Litigation , lawsuit , Aredia , mass tort , Zometa , torts

Fosamax MDL Jury: Drug Wasn't Defectively Designed, Didn't Cause Jaw Injury
Posted on 3 Oct 2011 by Tom Moylan

NEW YORK - A New York federal jury hearing the fourth Fosamax bellwether trial on Oct. 3 found that Merck's osteoporosis drug was not defectively designed and did not cause a plaintiff to develop osteonecrosis of the jaw (ONJ) ( In Re: Fosamax Products... Read More

Tags: osteonecrosis of the jaw , ONJ , Linda Secrest , Merck , drugs and devices , Litigation , osteoporosis drug , Linda Secrest v. Merck &amp , In Re: Fosamax Products Liability Litigation

Jury Awards $1.3 Million In Zometa Jaw Injury Trial After Botching 1st Verdict Form
Posted on 23 Sep 2013 by Tom Moylan

ORLANDO, Fla. — (Mealey’s) A Florida federal jury on Sept. 20 found that Novartis Pharmaceuticals Corp. failed to warn a cancer patient about the risk of osteonecrosis of the jaw (ONJ) and awarded her $1.3 million in medical expenses and non... Read More

Tags: drugs , Nancy Guenther , Damages , osteonecrosis of the jaw , et al. v. Novartis Pharmaceutical Corporation , Florida , ONJ , Novartis Pharmaceuticals Corp. , Litigation , Zometa , verdict

Jury Awards Plaintiff $10.4 Million For Injuries, Punitive Damages Linked To Novartis' Zometa
Posted on 5 Nov 2012 by Tom Moylan

CENTRAL ISLIP, N.Y. - (Mealey's) A New York federal jury on Nov. 2 found Novartis Pharmaceuticals Corp. liable for a woman's osteonecrosis of the jaw (ONJ) and awarded her $10.45 million, according to the parties ( Barbara Davids v. Novartis Pharmaceuticals... Read More

Tags: New York , drugs , punitive damages , osteonecrosis of the jaw , Novartis , Barbara Davids v. Novartis Pharmaceuticals Corporation , breast cancer , ONJ , bisphosphonate drug , Femara , Barbara Davids , Merck , Litigation , Fosamax , Zometa , osteoporosis

Jury Awards Plaintiff $285,000 In 5th Fosamax MDL Trial But Finds No Design Defect
Posted on 5 Feb 2013 by Tom Moylan

NEW YORK - (Mealey's) A New York federal jury on Feb. 5 ordered Novartis Pharmaceuticals Corp. to pay $285,000 to a plaintiff for allegedly failing to warn her or her doctor that Fosamax carries a risk of osteonecrosis of the jaw (ONJ) ( In Re: Fosamax... Read More

Tags: pharmaceutical litigation , osteonecrosis of the jaw , Rhoda E. Scheinberg v. Merck & Co. , ONJ , Merck , Novartis Pharmaceuticals Corp. , Litigation , multidistrict litigation , Rhonda E. Scheinberg , Fosamax , In Re: Fosamax Products Liability Litigation , Wyeth v. Levine

2nd Fosamax Bellwether Plaintiff Failed To Prove Causation, 2nd Circuit Affirms
Posted on 8 Nov 2010 by Tom Moylan

NEW YORK - (Mealey's) The second bellwether plaintiff in the Fosamax multidistrict litigation failed to produce evidence that the osteoporosis drug caused her osteonecrosis of the jaw (ONJ), a panel of the Second Circuit U.S. Court of Appeals ruled... Read More

Tags: drugs , osteonecrosis of the jaw , failure-to-warn claim , Bessie Flemings , Bessie L. Flemings v. Merck & Co. , ONJ , Fosamax MDL , e Second Circuit U.S. Court of Appeals , Litigation , multidistrict litigation , Fosamax , MDL

Novartis Wins Defense Verdict In Zometa Jaw Injury Trial
Posted on 26 May 2011 by Tom Moylan

BROOKLYN, N.Y. (Mealey's) A New York federal jury in the first federal Zometa trial found May 25 that the plaintiff did not prove by a preponderance of evidence that the Novartis Pharmaceuticals Corp. drug caused a decedent's osteonecrosis of... Read More

Tags: drugs , Karlene Hogan v. Novartis Pharmaceuticals , osteonecrosis of the jaw , Karlene Hogan , Novartis , ONJ , bisphosphonate drug , Litigation , metastasizing cancer , lawsuit , Zometa

Merck To Settle Suits Alleging Jaw Damage From Osteoporosis Drug
Posted on 10 Dec 2013 by Michael Lefkowitz

WHITEHOUSE STATION, N.J. — (Mealey's) Merck & Co. Inc. has agreed to pay $27.7 million to resolve product liability suits alleging that its osteoporosis drug Fosamax caused osteonecrosis of the jaw (ONJ), or bone death, according to a press... Read More

Tags: New York , drugs , Judicial Panel on Multidistrict Litigation , osteonecrosis of the jaw , product liability , Fosama , ONJ , Litigation , osteoporosis drug , Merck & Co. , bone death , In Re: Fosamax Products Liability Litigation